---
title: "Key facts: Baxter International appoints McDonnell; reports Q4 loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275802608.md"
description: "Baxter International Inc. appointed Michael R. McDonnell to its Board of Directors, effective February 13, 2026. Cathy R. Smith and Stephen H. Rusckowski will resign on the same date.1Baxter International Inc. reported a Q4 loss of $1.13 billion, with revenue at $2.97 billion, exceeding estimates. Adjusted EPS was 44 cents, below expectations, causing shares to drop 16%.234"
datetime: "2026-02-12T20:04:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275802608.md)
  - [en](https://longbridge.com/en/news/275802608.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275802608.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275802608.md) | [繁體中文](https://longbridge.com/zh-HK/news/275802608.md)


# Key facts: Baxter International appoints McDonnell; reports Q4 loss

-   Baxter International Inc. appointed Michael R. McDonnell to its Board of Directors, effective February 13, 2026. Cathy R. Smith and Stephen H. Rusckowski will resign on the same date.1
-   Baxter International Inc. reported a Q4 loss of $1.13 billion, with revenue at $2.97 billion, exceeding estimates. Adjusted EPS was 44 cents, below expectations, causing shares to drop 16%.234

### Related Stocks

- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [Baxter International Inc. (BAX.US)](https://longbridge.com/en/quote/BAX.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [Geoffrey Beran Rose Sells 7,732 Shares of Pulmonx (NASDAQ:LUNG) Stock](https://longbridge.com/en/news/277978473.md)
- [Pulmonx Q4 revenue beats expectations](https://longbridge.com/en/news/277833961.md)
- [Enovis Corporation $ENOV Shares Sold by Royce & Associates LP](https://longbridge.com/en/news/277474498.md)
- [J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma](https://longbridge.com/en/news/278091420.md)
- [/C O R R E C T I O N -- Johnson & Johnson/ | JNJ Stock News](https://longbridge.com/en/news/277699503.md)